Lilly puts name on tennis title

February 26, 2008
Back to TopCommentsE-mailPrintBookmark and Share
Tennis Logo

The local stop on the ATP Tour now will be known as The Indianapolis Tennis Championships Presented By Lilly. Eli Lilly-which will use the tournament to promote specific drugs such as Humalog and Cymbalta-signed a two-year deal, which sports marketing experts said is likely worth between $1.3 million and $1.6 million. In July 2007, tournament officials announced that Lilly had tripled its financial commitment to the tournament to help make up for the loss of the event’s title sponsor, Thomson’s RCA brand. Eli Lilly has been involved in the tournament for three decades, ITC Director Kevin Martin said. Martin and Lilly CEO Sidney Taurel began discussing the new title sponsorship deal 18 months ago, Martin said at a press conference today at the Indianapolis Artsgarden. Though sports marketers said the Lilly signing is a big announcement for the tournament, it likely doesn’t match the $1 million annually RCA paid to be title sponsor before it exited following the 2006 tournament.

Martin said the Lilly deal is a comprehensive sponsorship package that will include a multi-day health-and-wellness fair that Lilly and ITC officials will put on in conjunction with this year’s tournament, which will be July 12-20 at the Indianapolis Tennis Center on the IUPUI campus. Martin added that other sponsor announcements will be forthcoming, but he would not specify what those would be.
ADVERTISEMENT

Post a comment to this blog

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT
ADVERTISEMENT